Prediction of Lymphopenia and Survival with Baseline Absolute Lymphocyte Count and Irradiated Dose to Immune Cells in Patients with Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

被引:0
|
作者
Yang, G. [1 ]
Yoon, H. I. [2 ]
Lee, J. G. [1 ]
Kim, J. [1 ,3 ]
Kim, J. [1 ,3 ]
Kim, K. H. [1 ]
机构
[1] Yonsei Univ, Heavy Ion Therapy Res Inst, Dept Radiat Oncol, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2170
引用
收藏
页码:E77 / E78
页数:2
相关论文
共 50 条
  • [1] Prediction of delayed lymphopenia after chemoradiotherapy in non-small cell lung cancer
    Kang, B.
    Lee, J. H.
    Xue, L.
    Son, J.
    Wu, H.
    Kim, H. J.
    Kang, H.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S961 - S961
  • [2] Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
    Liu, FangJie
    Wu, YingJia
    Shao, JianHui
    Qiu, Bo
    Guo, SuPing
    Luo, QiaoTing
    Guo, JinYu
    Wang, DaQuan
    Chu, Chu
    Zhou, Rui
    Chen, NaiBin
    Ai, XinLei
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [4] A clinical nomogram based on absolute count of lymphocyte subsets for predicting overall survival in patients with non-small cell lung cancer
    Liu, Aqing
    Zhang, Guan
    Yang, Yanjie
    Xia, Ying
    Li, Wentao
    Liu, Yunhe
    Cui, Qian
    Wang, Dong
    Zhao, Jian
    Yu, Jianchun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
  • [5] The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study
    Karantanos, T.
    Karanika, S.
    Seth, B.
    Gignac, G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (02): : 206 - 212
  • [6] The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study
    T. Karantanos
    S. Karanika
    B. Seth
    G. Gignac
    Clinical and Translational Oncology, 2019, 21 : 206 - 212
  • [7] Survival of patients treated with high-dose radiotherapy & concurrent chemotherapy for unresectable non-small cell lung cancer
    Schild, Steven E.
    Graham, David L.
    Hillman, Shauna L.
    Vora, Sujay A.
    Garces, Yolanda, I
    Molina, Julian R.
    Shahidi, Homayoon
    Kugler, John W.
    Adjei, Alex A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S336 - S336
  • [8] Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy
    Yang, Gowoon
    Yoon, Hong In
    Lee, Joongyo
    Kim, Jihun
    Kim, Hojin
    Cho, Jaeho
    Lee, Chang Geol
    Chang, Jee Suk
    Cho, Yeona
    Kim, Jin Sung
    Kim, Kyung Hwan
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
  • [9] Impact Of Chemotherapy Response And Radiation Dose On Overall Survival In Patients With Inoperable Non-small Cell Lung Cancer Treated With Induction Chemotherapy Followed By Concurrent Chemoradiotherapy
    Grant, J.
    Gomez, D.
    Zhuang, Y.
    Chang, J.
    Komaki, R.
    Fossella, F.
    Gold, K.
    Liao, Z.
    Cox, J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S272 - S272
  • [10] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Bergamino, Milana
    Rullan, Antonio J.
    Saigi, Maria
    Peiro, Inmaculada
    Montanya, Eduard
    Palmero, Ramon
    Carlos Ruffinelli, Jose
    Navarro, Arturo
    Dolores Arnaiz, Maria
    Brao, Isabel
    Aso, Samantha
    Padrones, Susana
    Cardenal, Felipe
    Nadal, Ernest
    BMC CANCER, 2019, 19 (1)